| Risk factor . | OR . | P value . |
|---|---|---|
| Factors associated with development of any infection | ||
| History of radiation | 1.72 | .05 |
| Bilateral reconstruction | 2.81 | .003 |
| Seroma | 5.18 | .001 |
| Factors associated with development of major infection | ||
| Bilateral reconstruction | 2.36 | .03 |
| Seroma | 6.51 | .01 |
| Factors associated with implant failure due to infection | ||
| Bilateral reconstruction | 2.91 | .02 |
| Seroma | 5.51 | .001 |
| Factors associated with implant failure after development of major infection | ||
| Unincorporated ADM | 5.4 | .003 |
| Tissue expander | 3.56 | .01 |
| Hematoma | 3.5 | .13 |
| Serratia infection | 5 | .27 |
| Gram-negative infection | 4.8 | .2 |
| Risk factor . | OR . | P value . |
|---|---|---|
| Factors associated with development of any infection | ||
| History of radiation | 1.72 | .05 |
| Bilateral reconstruction | 2.81 | .003 |
| Seroma | 5.18 | .001 |
| Factors associated with development of major infection | ||
| Bilateral reconstruction | 2.36 | .03 |
| Seroma | 6.51 | .01 |
| Factors associated with implant failure due to infection | ||
| Bilateral reconstruction | 2.91 | .02 |
| Seroma | 5.51 | .001 |
| Factors associated with implant failure after development of major infection | ||
| Unincorporated ADM | 5.4 | .003 |
| Tissue expander | 3.56 | .01 |
| Hematoma | 3.5 | .13 |
| Serratia infection | 5 | .27 |
| Gram-negative infection | 4.8 | .2 |
ADM, acellular dermal matrix; OR, odds ratio.
| Risk factor . | OR . | P value . |
|---|---|---|
| Factors associated with development of any infection | ||
| History of radiation | 1.72 | .05 |
| Bilateral reconstruction | 2.81 | .003 |
| Seroma | 5.18 | .001 |
| Factors associated with development of major infection | ||
| Bilateral reconstruction | 2.36 | .03 |
| Seroma | 6.51 | .01 |
| Factors associated with implant failure due to infection | ||
| Bilateral reconstruction | 2.91 | .02 |
| Seroma | 5.51 | .001 |
| Factors associated with implant failure after development of major infection | ||
| Unincorporated ADM | 5.4 | .003 |
| Tissue expander | 3.56 | .01 |
| Hematoma | 3.5 | .13 |
| Serratia infection | 5 | .27 |
| Gram-negative infection | 4.8 | .2 |
| Risk factor . | OR . | P value . |
|---|---|---|
| Factors associated with development of any infection | ||
| History of radiation | 1.72 | .05 |
| Bilateral reconstruction | 2.81 | .003 |
| Seroma | 5.18 | .001 |
| Factors associated with development of major infection | ||
| Bilateral reconstruction | 2.36 | .03 |
| Seroma | 6.51 | .01 |
| Factors associated with implant failure due to infection | ||
| Bilateral reconstruction | 2.91 | .02 |
| Seroma | 5.51 | .001 |
| Factors associated with implant failure after development of major infection | ||
| Unincorporated ADM | 5.4 | .003 |
| Tissue expander | 3.56 | .01 |
| Hematoma | 3.5 | .13 |
| Serratia infection | 5 | .27 |
| Gram-negative infection | 4.8 | .2 |
ADM, acellular dermal matrix; OR, odds ratio.
This PDF is available to Subscribers Only
View Article Abstract & Purchase OptionsFor full access to this pdf, sign in to an existing account, or purchase an annual subscription.
